GSK Investigational Site

Osnabrück, Lower Saxony 49090

0 studies enrolling now · 8 studies all time

What they study most

Cerebrovascular Accident, Epilepsy, Epilepsy, Partial, Epilepsy, Tonic-Clonic, HIV Infections, Infection, Human Immunodeficiency Virus, Prostatic Hyperplasia, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dolutegravir Expanded Access Study — Completed
• A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Proof of Concept (POC) in Patients With Ischaemic Stroke — Stopped early
• Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2 — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures — Completed